Galvanize’s Aliya EX System Used in First Commercial Procedures for Ablation of Soft Tissue
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Galvanize Therapeutics announces first commercial procedures using Aliya EX system
The Aliya EX generator Galvanize Therapeutics has announced the completion of the first commercial procedures using its recently US Food and Drug Administration (FDA)-cleared Aliya EX system. The milestone marks the first clinical use of the Aliya EX system following its US FDA 510(k) clearance in May 2026 and the first commercial procedures across the Aliya pulsed electric field (PEF) platform’s two primary delivery pathways: percutaneous deliv…
Galvanize’s Aliya EX System Used in First Commercial Procedures for Ablation of Soft Tissue
August 17, 2026—Galvanize Therapeutics, Inc., a developer of pulsed electric field (PEF) therapies for oncology and chronic lung disease, announced the completion of the first commercial procedures using its Aliya EX system. The company noted that the procedures are the first clinical use of the Aliya EX system after the device received FDA 510(k) clearance for soft tissue ablation in May 2026 and the first commercial procedures across the Aliya…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
